Answers are grounded in this paper and cite their sources.
Background/Objectives: To describe SARS-CoV-2 positivity, temporal patterns, and associated factors among pregnant and postpartum women hospitalized with acute respiratory infection or febrile illness (ARFI) in Suzhou, China. Methods: Women who met the ARFI case definition between 2020 and 2024 were included and tested for SARS-CoV-2. Epidemiological and clinical characteristics, disease severity, and outcomes were compared between SARS-CoV-2-positive and non-SARS-CoV-2 ARFI cases. Multivariable logistic regression was used to identify factors associated with SARS-CoV-2 positivity. Results: Among 4219 pregnant and postpartum women hospitalized with ARFI and enrolled in surveillance, 512 (12.1%) tested positive for SARS-CoV-2. After excluding six women with influenza coinfection, the analytic cohort included 512 women who tested positive and 3701 who tested negative. SARS-CoV-2 positivity peaked in December 2022, May–June 2023, and July–August 2024. Among women admitted from December 2022 through December 2024, gestational diabetes mellitus was associated with higher odds of SARS-CoV-2 positivity after adjustment for admission year, vaccination status before admission, and other covariates (aOR 2.21, 95% CI 1.57–3.10). Conclusions: Among pregnant and postpartum women hospitalized with ARFI, gestational diabetes mellitus (GDM) was associated with higher odds of SARS-CoV-2 positivity. These findings support continued active surveillance for respiratory viral infections in this population during the post-emergency phase, with particular attention to women with GDM.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: